DeFinium Therapeutics Inc (DFTX) Stock Price, Quote & News

Company Profile

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Me...

Industry: Biotechnology

Sector: Healthcare

Phone: 212 220 6633

Website: definiumtx.com

Address:

One World Trade Center, Suite 8500, New York, United States

IBSpazzin Mar. 14 at 2:32 PM

$DFTX only green in my account.

0 · Reply

Framingtheworld Mar. 13 at 8:36 PM

$ATAI $HELP not a good look when others up over 100% from lows. $DFTX makes no sense even with bad management. Look out

1 · Reply

BobbyCucumber Mar. 13 at 6:53 PM

$DFTX

0 · Reply

Framingtheworld Mar. 13 at 5:13 PM

$HELP bad sign for $ATAI $DFTX when help has more to offer than both and hit new atl on good news last few weeks… wonder what this will be when Atai hit $1 again

0 · Reply

BankOnTheFuture Mar. 13 at 3:53 PM

$CMPS $DFTX $ATAI Geez. The Wednesday psychedelic sector bull run was only two days ago. Gave it all back.

0 · Reply

twiggs462 Mar. 13 at 3:15 AM

$DFTX DT-402 will make $DFTX a 20B company long term after DT-120 is approved. If a treatment could improve social functioning or learning, it could potentially reduce the number of therapy hours required over time. https://www.wsj.com/health/healthcare/autism-therapy-medicaid-payments-640aa435?st=DYgYyH&reflink=article_copyURL_share @WSJbusiness @WSJhealth @WSJmarkets

0 · Reply

goral17 Mar. 13 at 3:01 AM

$DFTX Even on my short. I'm tempted to exit. This one has burned me. Got damn is it hard for the shorties these days!

1 · Reply

goral17 Mar. 12 at 4:32 PM

$DFTX 🤔

2 · Reply

Framingtheworld Mar. 11 at 7:03 PM

$ATAI either everything is overvalued or $HELP is under you choose but as far as patents and phase 3 Helus pharma has everyone beat… idk what to think here. $DFTX $CMPS

6 · Reply

Thebullrun Mar. 11 at 2:04 PM

$BETRF $DFTX people!Understand what this company does and why people should take a real look at Betterlife. I’d rather take a pill at home safe and not trip out then in an institution tripping face.

1 · Reply

Definium Therapeutics Announces New Employee Inducement Grants

Feb 26, 2026, 9:57 PM EST - 16 days ago

Definium Therapeutics, Inc. (DFTX) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 4:01 PM EST - 17 days ago

Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates

Feb 24, 2026, 7:01 AM EST - 19 days ago

Definium Therapeutics to Participate at Upcoming Investor Conferences

Feb 19, 2026, 4:01 PM EST - 24 days ago

Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026

Jan 29, 2026, 7:00 AM EST - 6 weeks ago

Definium Therapeutics Appoints Roger Adsett to Board of Directors

Jan 20, 2026, 7:00 AM EST - 7 weeks ago

Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care

Jan 14, 2026, 7:16 PM EST - 2 months ago

Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

MMED

Jan 13, 2026, 7:00 AM EST - 2 months ago

Definium Therapeutics Common Shares to Trade under New Nasdaq Ticker Symbol “DFTX” Effective January 15, 2026

Jan 12, 2026, 7:00 AM EST - 2 months ago

MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026

Dec 18, 2025, 7:01 AM EST - 3 months ago

MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 15, 2025, 4:01 PM EST - 3 months ago

MindMed Announces New Employee Inducement Grant

Dec 1, 2025, 4:01 PM EST - 3 months ago

MindMed Announces New Employee Inducement Grants

Nov 6, 2025, 9:46 PM EST - 4 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:01 PM EST - 4 months ago

MindMed Reports Q3 2025 Financial Results and Business Updates

Nov 5, 2025, 7:01 AM EST - 4 months ago

MindMed to Participate in Upcoming Investor Conferences

Nov 3, 2025, 7:01 AM EST - 4 months ago

Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Oct 30, 2025, 4:01 PM EDT - 4 months ago

MindMed to Report Q3 2025 Financial Results on November 6, 2025

Oct 29, 2025, 10:14 PM EDT - 4 months ago

Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering

Oct 29, 2025, 4:01 PM EDT - 4 months ago

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Oct 14, 2025, 12:28 PM EDT - 5 months ago

MindMed Nears Pivotal Year: Strong Fundamentals Make It A Buy

Oct 13, 2025, 2:54 PM EDT - 5 months ago

Mind Medicine Analyst Cites Strong Phase 3 Pipeline For Anxiety, Depression

Sep 19, 2025, 7:00 AM EDT - 6 months ago

New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)

Sep 4, 2025, 11:05 AM EDT - 6 months ago

Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)

Aug 28, 2025, 7:00 AM EDT - 7 months ago

MindMed to Participate in September Investor Conferences

Jul 31, 2025, 9:48 PM EDT - 8 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 4:01 PM EDT - 8 months ago

MindMed Reports Q2 2025 Financial Results and Business Updates

Jul 24, 2025, 7:00 AM EDT - 8 months ago

MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025

May 28, 2025, 7:00 AM EDT - 10 months ago

MindMed to Participate in June Investor Conferences

May 27, 2025, 7:00 AM EDT - 10 months ago

MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer

May 13, 2025, 7:00 AM EDT - 10 months ago

MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference

May 8, 2025, 9:55 AM EDT - 11 months ago

Mind Medicine (MindMed) Inc. (MNMD) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:00 AM EDT - 11 months ago

MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates

Apr 24, 2025, 7:00 AM EDT - 11 months ago

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 15, 2025, 7:00 AM EDT - 11 months ago

MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)

Mar 17, 2025, 7:00 AM EDT - 1 year ago

MindMed Appoints Matt Wiley as Chief Commercial Officer

Mar 6, 2025, 12:10 PM EST - 1 year ago

Mind Medicine (MindMed) Inc. (MNMD) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 7:00 AM EST - 1 year ago

MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates

Mar 4, 2025, 7:00 AM EST - 1 year ago

MindMed to Present at Leerink's Global Healthcare Conference 2025

Feb 20, 2025, 7:00 AM EST - 1 year ago

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Feb 4, 2025, 7:00 AM EST - 1 year ago

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 30, 2025, 7:00 AM EST - 1 year ago

MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder

Dec 19, 2024, 7:00 AM EST - 1 year ago

MindMed to Be Added to the Nasdaq Biotechnology Index

Dec 16, 2024, 7:00 AM EST - 1 year ago

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)

Dec 11, 2024, 7:00 AM EST - 1 year ago

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress

Dec 5, 2024, 7:00 AM EST - 1 year ago

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

Dec 3, 2024, 7:00 AM EST - 1 year ago

MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy

Nov 18, 2024, 7:00 AM EST - 1 year ago

MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer

Nov 10, 2024, 9:55 AM EST - 1 year ago

Mind Medicine: No News = Good News

Nov 7, 2024, 8:06 PM EST - 1 year ago

Mind Medicine (MindMed) Inc. (MNMD) Q3 2024 Earnings Call Transcript

IBSpazzin Mar. 14 at 2:32 PM

$DFTX only green in my account.

0 · Reply

Framingtheworld Mar. 13 at 8:36 PM

$ATAI $HELP not a good look when others up over 100% from lows. $DFTX makes no sense even with bad management. Look out

1 · Reply

BobbyCucumber Mar. 13 at 6:53 PM

$DFTX

0 · Reply

Framingtheworld Mar. 13 at 5:13 PM

$HELP bad sign for $ATAI $DFTX when help has more to offer than both and hit new atl on good news last few weeks… wonder what this will be when Atai hit $1 again

0 · Reply

BankOnTheFuture Mar. 13 at 3:53 PM

$CMPS $DFTX $ATAI Geez. The Wednesday psychedelic sector bull run was only two days ago. Gave it all back.

0 · Reply

twiggs462 Mar. 13 at 3:15 AM

0 · Reply

goral17 Mar. 13 at 3:01 AM

$DFTX Even on my short. I'm tempted to exit. This one has burned me. Got damn is it hard for the shorties these days!

1 · Reply

goral17 Mar. 12 at 4:32 PM

$DFTX 🤔

2 · Reply

Framingtheworld Mar. 11 at 7:03 PM

$ATAI either everything is overvalued or $HELP is under you choose but as far as patents and phase 3 Helus pharma has everyone beat… idk what to think here. $DFTX $CMPS

6 · Reply

Thebullrun Mar. 11 at 2:04 PM

1 · Reply

BullsVSBearsVSYoMomma Mar. 11 at 5:39 AM

$DFTX Haha @goral17 you sure you want to add to that short? Smart money agrees to disagree

0 · Reply

Rocketzz Mar. 11 at 4:25 AM

$DFTX buyouts get more expensive everyday, fine by me.

0 · Reply

Thebullrun Mar. 11 at 1:55 AM

$BETRF #BETRF BETTERLIFE PHARMA #OTCQB & $DFTX Therapeutics. #NASDAQ comparison. Check it out! https://youtu.be/RfOtMv08P5o?si=h5pFFUz9HO9oP7GJ via @YouTube

0 · Reply

Belagio Mar. 10 at 11:59 PM

NEXT STOP FOR $DFTX = $30+ $DFTX STRONG LIKE A BULL =

0 · Reply

goral17 Mar. 10 at 9:35 PM

$DFTX Wow. Crazy move. Above $20 I add to my short. 😜

2 · Reply

BillionerOfKing Mar. 10 at 9:30 PM

$DFTX Current Stock Price: $19.05 Contracts to trade: $19.0 DFTX Mar 20 2026 Call Entry: $0.75 Exit: $1.37 ROI: 83% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply